Preview

Drug development & registration

Advanced search
Fullscreen

For citations:


Dubovik N.S., Guranda D.F., Ramenskaya G.V., Tovbin D.G., Tarasov D.N., Savchenko A.Yu., Arnautov V.S. Development and Validation of the HPLC Method for Quantification of the Innovative Drug DD217, Factor Xa Inhibitor, in Rat Plasma for a Pharmacokinetic Study. Drug development & registration. 2022;11(2):197-206. (In Russ.) https://doi.org/10.33380/2305-2066-2022-11-2-197-206

Views PDF (Rus): 390


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2305-2066 (Print)
ISSN 2658-5049 (Online)